Johnson & Johnson has announced that Mark B. McClellan, M.D., Ph.D., Senior Fellow in Economic Studies, and Director of the Initiative on Value and Innovation in Health Care, Brookings Institution, will join its Board of Directors on October 15, 2013.

McClellan will serve on the Regulatory, Compliance & Government Affairs Committee and the Science, Technology & Sustainability Committee of the Board.

As former commissioner of the U.S. Food and Drug Administration (FDA) from 2002 to 2004, and as the former administrator of the Centers for Medicare & Medicaid Services for the U.S. Department of Health and Human Services from 2004 to 2006, McClellan has more than two decades of public service and academic research experience.

While at FDA, Dr. McClellan implemented the Critical Path Initiative, regulatory reforms to modernize pharmaceutical manufacturing, and new initiatives on food safety and security.

From 2001 to 2002, McClellan served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House. During President William J. Clinton’s administration, he held the position of deputy assistant secretary of the Treasury for economic policy.

“Dr. McClellan has a distinguished record in the public sector as well as a deep understanding and vision for the future of health care,” said Alex Gorsky, Chairman and CEO of Johnson & Johnson. “Mark shares our aspiration to help people live longer, healthier and happier lives and personally is committed to improving health care across the globe. He will be a valued leader on our Board.”